AU2012355956B2 - Methods and compositions for the treatment of diverticulosis - Google Patents

Methods and compositions for the treatment of diverticulosis

Info

Publication number
AU2012355956B2
AU2012355956B2 AU2012355956A AU2012355956A AU2012355956B2 AU 2012355956 B2 AU2012355956 B2 AU 2012355956B2 AU 2012355956 A AU2012355956 A AU 2012355956A AU 2012355956 A AU2012355956 A AU 2012355956A AU 2012355956 B2 AU2012355956 B2 AU 2012355956B2
Authority
AU
Australia
Prior art keywords
glutamine
diverticulosis
compositions
salt
fiber
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2012355956A
Other languages
English (en)
Other versions
AU2012355956A1 (en
Inventor
Yutaka Niihara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emmaus Medical Inc
Original Assignee
Emmaus Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emmaus Medical Inc filed Critical Emmaus Medical Inc
Publication of AU2012355956A1 publication Critical patent/AU2012355956A1/en
Application granted granted Critical
Publication of AU2012355956B2 publication Critical patent/AU2012355956B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/24—Cellulose or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU2012355956A 2011-12-19 2012-12-14 Methods and compositions for the treatment of diverticulosis Active AU2012355956B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161630831P 2011-12-19 2011-12-19
US61/630,831 2011-12-19
PCT/US2012/000576 WO2013095681A1 (en) 2011-12-19 2012-12-14 Methods and compositions for the treatment of diverticulosis

Publications (2)

Publication Number Publication Date
AU2012355956A1 AU2012355956A1 (en) 2014-07-03
AU2012355956B2 true AU2012355956B2 (en) 2016-07-21

Family

ID=48669319

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012355956A Active AU2012355956B2 (en) 2011-12-19 2012-12-14 Methods and compositions for the treatment of diverticulosis

Country Status (13)

Country Link
US (4) US9616041B2 (cg-RX-API-DMAC7.html)
EP (2) EP3603631B1 (cg-RX-API-DMAC7.html)
JP (1) JP6060176B2 (cg-RX-API-DMAC7.html)
KR (4) KR20170087531A (cg-RX-API-DMAC7.html)
CN (1) CN104114165B (cg-RX-API-DMAC7.html)
AU (1) AU2012355956B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014014765A8 (cg-RX-API-DMAC7.html)
DK (1) DK2793875T3 (cg-RX-API-DMAC7.html)
ES (1) ES2770585T3 (cg-RX-API-DMAC7.html)
IN (1) IN2014KN01255A (cg-RX-API-DMAC7.html)
MX (1) MX351688B (cg-RX-API-DMAC7.html)
RU (2) RU2733396C2 (cg-RX-API-DMAC7.html)
WO (1) WO2013095681A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2793875T3 (da) * 2011-12-19 2020-02-24 Emmaus Medical Inc Fremgangsmåder og sammensætninger til behandlingen af diverticulosis
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
EP3790545A4 (en) * 2019-07-17 2021-07-28 Emmaus Medical, Inc. METHODS AND COMPOSITIONS FOR TREATMENT OF SICKLE CLEANEMIA AND THALASSEMIA
US20230053227A1 (en) * 2021-07-27 2023-02-16 G&S Laboratories, Inc. Dietary fiber compositions

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040005304A1 (en) * 2002-07-08 2004-01-08 Mak Wood, Inc. Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
US20040096479A1 (en) * 2001-08-24 2004-05-20 Levine Scott David Ultra-high fiber supplement and method of cancer reduction
US20050058671A1 (en) * 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders
US20080003265A1 (en) * 2006-06-28 2008-01-03 John Francis Casey Protein and fiber containing dietary supplement

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1362587A1 (en) * 1994-01-11 2003-11-19 Stichting Zofia Use of glutamine for treating low arginine levels in the animal or human body
JP2000060487A (ja) * 1998-08-27 2000-02-29 Kao Corp 便秘改善剤
US7988989B2 (en) * 2003-05-09 2011-08-02 Freedom Health, Llc Nutritional product for enhancing growth and/or strengthening the immune system of equine foals
US8512789B2 (en) * 2005-11-23 2013-08-20 The Coca-Cola Company High-potency sweetener composition with dietary fiber and compositions sweetened therewith
PL2086346T3 (pl) * 2006-11-07 2013-06-28 Procter & Gamble Kompozycje zawierające błonnik oraz sposoby ich wytwarzania i zastosowanie
RU2454730C1 (ru) * 2011-03-15 2012-06-27 Александр Михайлович Пузиков Способ лечения дивертикулеза в эксперименте
DK2793875T3 (da) * 2011-12-19 2020-02-24 Emmaus Medical Inc Fremgangsmåder og sammensætninger til behandlingen af diverticulosis

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040096479A1 (en) * 2001-08-24 2004-05-20 Levine Scott David Ultra-high fiber supplement and method of cancer reduction
US20040005304A1 (en) * 2002-07-08 2004-01-08 Mak Wood, Inc. Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions
US20050058671A1 (en) * 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders
US20080003265A1 (en) * 2006-06-28 2008-01-03 John Francis Casey Protein and fiber containing dietary supplement

Also Published As

Publication number Publication date
MX2014007382A (es) 2014-09-22
US11304918B2 (en) 2022-04-19
ES2770585T3 (es) 2020-07-02
KR20140103281A (ko) 2014-08-26
KR101848722B1 (ko) 2018-04-13
EP2793875A4 (en) 2015-06-03
US20190201361A1 (en) 2019-07-04
EP2793875B1 (en) 2020-02-05
JP6060176B2 (ja) 2017-01-11
US10258586B2 (en) 2019-04-16
AU2012355956A1 (en) 2014-07-03
US9616041B2 (en) 2017-04-11
RU2662917C2 (ru) 2018-07-31
RU2733396C2 (ru) 2020-10-01
KR20170038111A (ko) 2017-04-05
MX351688B (es) 2017-10-25
DK2793875T3 (da) 2020-02-24
RU2014123433A (ru) 2016-02-10
RU2018126834A3 (cg-RX-API-DMAC7.html) 2019-04-25
US20220202758A1 (en) 2022-06-30
EP3603631A1 (en) 2020-02-05
KR20180039187A (ko) 2018-04-17
EP3603631B1 (en) 2023-11-29
RU2018126834A (ru) 2019-03-14
EP2793875A1 (en) 2014-10-29
US20170157080A1 (en) 2017-06-08
CN104114165A (zh) 2014-10-22
CN104114165B (zh) 2016-10-19
KR20170087531A (ko) 2017-07-28
BR112014014765A2 (pt) 2017-06-13
EP3603631C0 (en) 2023-11-29
IN2014KN01255A (en) 2015-10-16
JP2015500340A (ja) 2015-01-05
US20130178531A1 (en) 2013-07-11
WO2013095681A1 (en) 2013-06-27
BR112014014765A8 (pt) 2017-07-04

Similar Documents

Publication Publication Date Title
US20220202758A1 (en) Methods and compositions for the treatment of diverticulosis
CN106687107A (zh) 抗产甲烷组合物及其用途
US20120009278A1 (en) Composition To Retard the Onset of Symptoms of Alzheimer's Disease
CN109806250A (zh) 一种含羟基脲的药物组合物的应用
JPH11116475A (ja) 炎症性腸疾患予防及び／又は治療剤
JP4355967B2 (ja) 医薬組成物
JPWO2006098524A1 (ja) ストレスによる腸疾患の予防・治療剤
JP2024508514A (ja) 選択的ｃｂ２受容体アゴニストによる処置の方法
JP2014505079A (ja) ビタミンｄおよびメトホルミン含有医薬組成物
WO2021193856A1 (ja) 腎機能保護剤
JP2013087108A (ja) 炎症性腸疾患の予防または治療剤
JP7763751B2 (ja) リファキシミン液体製剤
EP2537528B1 (en) Pharmaceutical compositions containing beta- and alpha-galactosidase and their use in the treatment of gastroesophageal reflux disease
Yadav et al. A Review on the Pharmacokinetics and Toxicological Profile of Rabeprazole
JP6143215B2 (ja) 高脂肪食への嗜好性を軽減させるための医薬組成物、飲食品組成物または飲食品添加剤
JP6281919B2 (ja) 高脂肪食への嗜好性を軽減させるための医薬組成物、飲食品組成物または飲食品添加剤
CN118178365A (zh) 石斛酚及其组合物在制备预防和/或治疗消化道炎症的药物或功能食品中的应用
CA3129064A1 (en) Compositions and methods for the treatment of constipation and other ailments of the gastrointestinal system
JPWO2011034006A1 (ja) 血液中の尿酸値を低下させるための組成物
Hiremath Ketoalfa-DS, The First Globally Approved Double Strength Alpha Ketoanalogues In The Management Of Nitrogenous Waste Of CKD Patients
JP2007320949A (ja) 血糖値上昇抑制剤

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)